Email Updates
Study
Programmable infusion pumps in ICUs: an analysis of corresponding adverse drug events.
January 23, 2008
Nuckols TK, Bower AG, Paddock SM, et al. J Gen Intern Med. 2008;23 Suppl 1:41-5.
Adoption of smart infusion pump technology was intended to improve medication safety, but past reports describe the ability of nurses to create work-arounds. This study examined preventable intravenous adverse drug events (IV-ADEs) and discovered that only 4% could be intercepted by a smart pump. Investigators reviewed medical records, both before and after adoption of smart pumps, to draw these conclusions. They also provide a qualitative analysis of errors causing preventable IV-ADEs and propose solutions that would improve smart pump technology.
Related Resources From the Same Author(s)
Related Resources
